Featured Research

from universities, journals, and other organizations

Folic Acid Lowers Risk Of Cardiovascular Disease

Date:
April 5, 1999
Source:
University Of Michigan
Summary:
University of Michigan scientists have solved the mystery behind folic acid's ability to reduce amounts of a compound called homocysteine, which is associated with an increased risk of heart attacks, strokes and birth defects in humans.

ANN ARBOR---University of Michigan scientists have solved the mystery behind folic acid's ability to reduce amounts of a compound called homocysteine, which is associated with an increased risk of heart attacks, strokes and birth defects in humans.

Related Articles


A team of U-M researchers led by Rowena G. Matthews, Ph.D., and Martha L. Ludwig, Ph.D., discovered the chemical and structural basis for folic acid's effectiveness while conducting research on an enzyme called methylenetetrahydrofolate reductase (MTHFR). This enzyme with the tongue-twisting name catalyzes a critical step in the biochemical chain reaction within cells that converts homocysteine to an essential amino acid called methionine. The U-M study is being published in the April 1 issue of Nature Structural Biology.

"This work illustrates why basic scientific research is so important," said Matthews, the G. Robert Greenberg Distinguished University Professor of Biological Chemistry and chair of the U-M's Biophysics Research Division. "Our original goal was simply to learn more about the biochemistry of MTHFR. We had no prior indication of any specific health-related application for our work, nor did we imagine that this enzyme would prove to be so important for human health.

"Much of the credit should go to the National Institute of General Medical Sciences of the National Institutes of Health," Matthews added, "because they continue to provide funding for this type of untargeted basic research."

Since the 1970s, researchers have known that administration of folic acid dramatically protects against the development of birth defects like spina bifida in humans. More recent evidence has suggested a correlation between high levels of homocysteine in blood and an increased risk of cardiovascular disease or spina bifida. In the mid-1990s, scientists discovered that increased folic acid intake reduced homocysteine. But no one understood how folic acid exerted its effect until the U-M study.

Using X-ray crystallography, Ludwig, Matthews and colleagues were able to picture the molecular structure of MTHFR from the bacterium, E. coli. "We used E. coli as a surrogate for human MTHFR, because there is a high degree of similarity between the two enzymes and human MTHFR is not yet available for biochemical analysis," said Ludwig, a professor of biological chemistry in the U-M Medical School and research biophysicist in the U-M's Biophysics Research Division.

Nestled within the barrel-shaped MTHFR molecule is a vitamin-derived molecule called flavin adenine dinucleotide or FAD. "The critical discovery in our work was that a common mutation in MTHFR promotes the loss of FAD from the enzyme," Matthews said. "If FAD is lost, the enzyme can't do its job. If the enzyme is inactivated, the conversion to methionine cannot take place and homocysteine builds up in blood plasma."

According to Matthews, about 10 percent of people have abnormally high levels of homocysteine, because they inherited a genetic mutation from both parents that alters the DNA specifying their MTHFR enzymes. "Mutated MTHFR is 11 times more susceptible to loss of this essential flavin molecule than the normal enzyme," Matthews said.

"Increased levels of folates help bind FAD more tightly to MTHFR---protecting the enzyme against heat inactivation and allowing the homocysteine-to-methionine conversion pathway to proceed normally," Ludwig said. "Our results suggest that folic acid supplementation will reduce homocysteine levels for normal humans as well as those with the mutant MTHFR."

Collaborators on the U-M study included Brian D. Guenther, postdoctoral fellow, graduate students Christal A. Sheppard from U-M and Pamela Tran from McGill University, and Rima Rozen, a professor at Montreal Children's Hospital and McGill University.

The research was supported by the National Institute of General Medical Sciences of the National Institutes of Health. Rozen received additional funding for this study from the Medical Research Council of Canada.


Story Source:

The above story is based on materials provided by University Of Michigan. Note: Materials may be edited for content and length.


Cite This Page:

University Of Michigan. "Folic Acid Lowers Risk Of Cardiovascular Disease." ScienceDaily. ScienceDaily, 5 April 1999. <www.sciencedaily.com/releases/1999/04/990405065821.htm>.
University Of Michigan. (1999, April 5). Folic Acid Lowers Risk Of Cardiovascular Disease. ScienceDaily. Retrieved December 22, 2014 from www.sciencedaily.com/releases/1999/04/990405065821.htm
University Of Michigan. "Folic Acid Lowers Risk Of Cardiovascular Disease." ScienceDaily. www.sciencedaily.com/releases/1999/04/990405065821.htm (accessed December 22, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Monday, December 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Touch-Free Smart Phone Empowers Mobility-Impaired

Touch-Free Smart Phone Empowers Mobility-Impaired

Reuters - Innovations Video Online (Dec. 21, 2014) A touch-free phone developed in Israel enables the mobility-impaired to operate smart phones with just a movement of the head. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Earthworms Provide Cancer-Fighting Bacteria

Earthworms Provide Cancer-Fighting Bacteria

Reuters - Innovations Video Online (Dec. 21, 2014) Polish scientists isolate bacteria from earthworm intestines which they say may be used in antibiotics and cancer treatments. Suzannah Butcher reports. Video provided by Reuters
Powered by NewsLook.com
Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Existing Chemical Compounds Could Revive Failing Antibiotics, Says Danish Scientist

Reuters - Innovations Video Online (Dec. 21, 2014) A team of scientists led by Danish chemist Jorn Christensen says they have isolated two chemical compounds within an existing antipsychotic medication that could be used to help a range of failing antibiotics work against killer bacterial infections, such as Tuberculosis. Jim Drury went to meet him. Video provided by Reuters
Powered by NewsLook.com
Hugging It Out Could Help You Ward Off A Cold

Hugging It Out Could Help You Ward Off A Cold

Newsy (Dec. 21, 2014) Carnegie Mellon researchers found frequent hugs can help people avoid stress-related illnesses. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins